Papers to be published in forthcoming issues
Amyloid deposits in the bone marrow
Plasmacytoma occurring in scar tissue
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
MECHANISM OF ACTION OF PURINE ANALOGUES IN CHRONIC LYMPHOCYTIC LEUKAEMIA
SIX CHARACTERS IN SEARCH OF AN AUTHOR
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand
HLA-DRB1*16-restricted recognition of myeloid cells, including CD34+ CML progenitor cells
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia
Growth regulation by p27Kip1 is abrogated by multiple mechanisms in aggressive malignant lymphomas
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders
Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK
Thalidomide and dexamethasone for resistant multiple myeloma
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias
Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias
Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura
Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia
Functional inhibitory human leucocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis
Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions
IS MACROCYTOSIS A FAVOURABLE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROME PATIENTS WITHOUT INCREASED BLASTS?
NOVEL COMBINATION CHEMOTHERAPY FOR PRIMARY (AL) AMYLOIDOSIS MYELOMA
SUCCESSFUL TREATMENT OF MULTICENTRIC CASTLEMAN'S DISEASE WITH BILATERAL ORBITAL TUMOUR USING RITUXIMAB